会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • PEPTIDYL DERIVATIVES AS METALLOPROTEINASE INHIBITORS
    • PEPTIDYADERDATE ALS INHIBITOREN VON METROOPROTEINASE
    • EP0648205B1
    • 1999-07-14
    • EP94913709.5
    • 1994-04-27
    • CELLTECH THERAPEUTICS LIMITED
    • MORPHY, Richard, JohnMILLICAN, Andrew, Thomas
    • C07C323/60C07D295/08C07C259/06C07D285/38C07C317/50A61K31/16
    • C07D285/38A61K41/00C07C317/50C07C323/60C07C323/61C07C2601/02
    • Compounds of formula (1) are described where R represents a -CONHOR6 [where R6 is a hydrogen atom or an acyl group], carboxyl (-CO¿2?H), esterified carboxyl, -SR?6¿ or -P(O)(X?1R7)- -X2R8¿ group, where X?1 and X2¿, which may be the same or different, is each an oxygen or sulphur atom and R?7 and R8¿, which may be the same or different each represents a hydrogen atom or an optionally substituted alkyl, aryl, or aralkyl group; R1 represents a hydrogen atom or an optionally substituted alkyl, alkenyl, aryl, aralkyl, heteroaralkyl or heteroarylthioalkyl group, R2 represents a group -Z2(CH2)mZ1-Ar wherein Ar is an aryl or heteroaryl group, Z?1 and Z2¿, which may be the same or different, is each a bond or a heteroatom, and m is zero or an integer 1 to 6 with the proviso that when m is zero, Z2 is a bond, and Z1 is a heteroatom; R3 represents a hydrogen atom or an alkyl group; R4 represents a hydrogen atom or an alkyl group; R5 represents a group -C(R?9)(R10)Het-R11¿, wherein R?9 and R10¿ which may be the same or different is each an optionally substituted alkyl or alkenyl group optionally interrupted by one or more -O- or -S- atoms or -N(R12)- groups (where R12 is a hydrogen atom or an optionally substituted alkyl group), or an optionally substituted cycloalkyl, cycloalkenyl, aryl or heteroaryl group, or R?9 and R10¿ together with the carbon atom to which they are attached are linked together to form an optionally substituted cycloalkyl or cycloalkenyl group, Het is -O-, -S(O)¿p?- [where p is zero, or an integer 1 or 2] or -N(R?12¿)-, and R11 is a hydrogen atom or an aliphatic, cycloaliphatic, heterocycloaliphatic, aromatic, or heteroaromatic group; X is an amino (-NH¿2?), substituted amino, hydroxyl or substituted hydroxyl group, or is linked to the atom of group Het in R?5¿ to form a chain -X-Alk-R5- where X is -N(R12)-, Alk is an optionally substituted alkylene chain and R5 is -Het-C(R9)(R10)-; and the salts, solvates, hydrates and prodrugs thereof. The compounds are orally active metalloproteinase inhibitors and in particular have a selective gelatinase action, have a long duration of action, and may be of use in the prophylaxis or treatment of diseases or disorders in which stromelysis, collagenase or gelatinase have a role, for example in the treatment of cancer to control the development of tumor metastases.
    • PCT No.PCT / GB94 / 00895 Sec。 371日期:1995年2月6日 102(e)日期1995年2月6日PCT 1994年4月27日PCT PCT。 公开号WO94 / 25434 日期:1994年11月10日公开了作为口服活性金属蛋白酶抑制剂的肽基衍生物。 肽基衍生物具有选择性明胶酶作用,具有长的作用持续时间,并且可用于预防或治疗其中溶质,胶原酶或明胶酶具有作用的疾病或病症,例如用于治疗癌症以控制 肿瘤转移的发展。